KELLY FIELDS: Open Payments
NPI 1306828181 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 13 payments from 8 companies in 2025. Trend: 2023 $304 · 2024 $392 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| Novo Nordisk Inc | 2 | $159 |
| ABBVIE INC. | 3 | $108 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| CooperSurgical, Inc. | 1 | $15 |
Products named: REXULTI, Wegovy, UBRELVY, QULIPTA, KEVEYIS, KYPHON EXPRESS II KYPHOPAK TRAY, SPRAVATO, Paragard T 380A.
Industry payments across NE — which companies pay providers there.
